Future of R/R DLBCL
A panel of experts discuss the future of R/R DLBCL treatment and review some recent data from the 2022 ASH meeting.
Potential Role of CAR T-cell Therapy in the Front-line Setting for Patients with R/R DLBCL
Experts discuss the potential use of CAR T-cell therapy in the front line setting as well as reviewing the use of tafasitamab from the FRONT-MIND and FIRST-MIND trials.
Sequencing Therapies in Patients with R/R DLBCL
Insightful discussion among a panel of oncologists on how to best sequence therapies for patients with R/R DLBCL.
ZUMA-7: Clinical Implications
Experts review some of the safety outcomes from the ZUMA-7 trial as well as discussing the clinical implications of the ZUMA-7 trial into their practice.
Eligibility Criteria for CAR T-Cell Therapy in R/R DLBCL
An overview of the ZUMA-7 and the TRANSFORM trial as well as reviewing eligibility criteria for patients who might receive CAR-T therapy.
Role of CAR T-cell Therapy in Patients with R/R DLBCL
Panel of experts discuss where CAR T-cell therapy might fit into the treatment landscape for patients with R/R DLBCL.
L-MIND: Review of Long-Term Analyses Data
Comprehensive insight into the L-MIND trial including a review of efficacy outcomes as well as discussing the implications of the data into clinical practice.
Treatment Options for Patients with R/R DLBCL
Experts discuss which factors are considered when choosing treatment options for patients with R/R DLBCL as well as reviewing the mechanism of tafasitamab.
An Overview of R/R DLBCL
Insightful discussion among experts into a brief overview of relapsed/refractory DLBCL (R/R DLBCL).
Front-Line Treatment Options for Patients with DLBCL
Expert oncologists provide a brief overview of front-line treatment options for patients diagnosed with double large b-cell lymphoma (DLBCL).
Medicaid Expansion Improves Survival in Pancreatic, Gastric Cancers, Potentially Reducing Disparities
Telephone-Based Weight Loss Program Is Effective for Breast Cancer Survivors
Pembrolizumab Plus Chemo With or Without Bevacizumab Maintains OS Benefit in Frontline Cervical Cancer
Minimally Invasive Distal Pancreatectomy Provides Effective Alternative in Resectable Pancreatic Cancer
2 Clarke Drive Cranbury, NJ 08512